http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111053739-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02c8838ede43eba2b24c6fde69855e82 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate | 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c1758b792cc7ca016035631ec34e3f9 |
| publicationDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111053739-A |
| titleOfInvention | A kind of enrofloxacin nano-emulsion solution for treating poultry mycoplasma synovial disease |
| abstract | The invention discloses an enrofloxacin nano-emulsion solution for treating poultry mycoplasma synovialis disease. The nano-emulsion is prepared by the following method: preparing raw materials, and the parts by weight of the raw materials are: enrofloxacin 5- 15 parts, 5-15 parts of oil phase, 5-20 parts of surfactant, 5-20 parts of co-surfactant, 30-80 parts of water phase; add enrofloxacin, surfactant, co-surfactant in the reaction device The active agent is dispersed in the water phase by stirring, ultrasonic or homogenization to obtain an emulsion; the emulsion is slowly added to the oil phase, nitrogen is driven to drive oxygen, and a mixture of initiators is added; the above reaction is carried out external cooling, polymerization , that is, enrofloxacin nano-emulsion solution. The object of the present invention is to provide a kind of enrofloxacin nano-microemulsion solution for the treatment of poultry mycoplasma synovialis disease, adopting the nano-microemulsion preparation process effect is more stable than ordinary oral solution, and exhibits more stable performance to poultry mycoplasma synovialis. good therapeutic effect. |
| priorityDate | 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.